Abstract
Background:
In recent years, Canadian health care professionals have observed an increase in vaccine refusal. The objective of this study is to review published literature and identify the main themes related to vaccine hesitancy and barriers to vaccination in Canadian adults and recent immigrants.
Methods:
A qualitative systematic review was performed. A comprehensive search of MEDLINE (1946 to January 2021) and EMBASE (1974 to January 2021) was conducted to identify existing literature that addressed the primary research question. Studies were eligible for inclusion if the study population involved 1) the general population, 2) Indigenous populations, 3) recent immigrants to Canada or 4) Canadian health care professionals.
Results:
Thirty-four studies were included with a focus on the general population (n = 22), health care professionals (n = 10) and recent immigrant populations (n = 2). The most frequently reported barriers were lack of vaccine information (41%), lack of access to vaccination (38%), fear of adverse reactions (38%), financial reasons (29%), lack of awareness of vaccine existence (29%), antivaccine sentiments (24%), notion that older adults do not need vaccination (18%), misconceptions on vaccine effectiveness (12%), potential sexual health promotion stigma (6%) and fear of needles (3%).
Interpretation:
Barriers to vaccination among Canadians and recent immigrants continue to be a challenge in the health care system.
Conclusions:
The greatest yield in improving vaccination rates is likely to come from supporting vaccine-hesitant individuals in shifting their thinking to greater vaccine acceptance. Pharmacists are well positioned to address vaccine hesitancy and involvement through education, facilitation and administration of vaccines. Can Pharm J (Ott) 2022;155:xx-xx.
Introduction
Vaccines and vaccination programs prevent millions of deaths annually around the world. 1 In Canada, vaccines have eliminated, contained and controlled diseases that were once very common. 2 Unfortunately, vaccine hesitancy is on the rise in many countries, including Canada. 3 The World Health Organization defines vaccine hesitancy as suboptimal vaccination coverage due to delay in acceptance or refusal of vaccines despite availability of vaccination services. 4 A 2018 survey of Canadian health care professionals reported that 26% of family physicians have observed an increase in vaccine refusal over the past 5 years. 5 The measles, mumps and rubella (MMR) vaccine had the highest rate of refusal, and the most common reason for refusal is knowing someone who has experienced an adverse effect from a vaccine. 5 Infants and children are particularly susceptible to vaccine-preventable diseases, and guidance is available for medical professionals to address parental vaccine hesitancy in primary care. 6 Immunizations are important for adults to restore waning immunity and to build new immunity against diseases that are more common in adults. 7
During the coronavirus disease 2019 (COVID-19) pandemic, understanding and addressing vaccine hesitancy to increase individual and herd immunity are important as vaccines become increasingly available. This article reviews the published literature and identifies the main themes related to vaccine hesitancy and barriers to vaccination in Canadian adults and recent immigrants to Canada. These findings can inform future vaccination initiatives and messages for undervaccinated Canadian adults.
Methods
This qualitative systematic review was performed and reported in compliance with the recommendations from the Preferred Reporting of Systematic Reviews and Meta-Analyses (PRISMA). 8
Search strategy
A comprehensive search of MEDLINE (1946 to January 2021) and EMBASE (1974 to January 2021) was conducted to identify existing literature that addressed the primary research question. The search terms and Boolean used in MEDLINE and EMBASE are outlined in Appendix 1.
Selection of studies
Studies of vaccine hesitancy and barriers to vaccination in Canada were eligible for inclusion if the study population involved 1) the general population, 2) Indigenous populations, 3) recent immigrants to Canada and 4) Canadian health care professionals. Exclusion criteria applied during preliminary screening were studies involving 1) pediatric patients, 2) parents’ vaccine hesitancy and barriers towards vaccinating their children, 3) specific conditions (e.g., pregnancy, breastfeeding, rheumatoid arthritis, asthma) and 4) specific populations (e.g., sex workers). Two authors (DS, BG) screened the search results for potentially relevant studies. Potentially relevant citations were then reviewed in full to determine whether the predefined inclusion criteria were met.
Data extraction and management
Data from each included study were extracted and tabulated. Extracted data included authors, language, study design, year of publication, type of vaccine, study population, barriers to vaccination and limitations. Data were first extracted by 1 author (DS), then checked by the second (BG); disagreements or inconsistencies regarding data extraction were resolved by discussion and consensus.
Data analysis
Descriptive analyses were performed on data extracted from the included studies.
Results
The search results and flow diagram are outlined in Appendix 2, available at www.cpjournal.ca. The initial search yielded 428 studies, of which a total of 34 studies met the criteria and were included in this review (Table 1).9 -42 Among included studies, 22 (65%) focused on the general population, 10 (29%) focused on health care professionals and 2 (6%) focused on recent immigrant populations.
Table 1.
Characteristics of included studies
Study and year | Research question | Study design | Context/setting/sample | Barriers identified | Limitations |
---|---|---|---|---|---|
McIntyre et al., 2014 9 | Self-perceived influences among older adults in deciding whether to take or not take the seasonal influenza vaccine | Six 60-minute focus group interviews | Southwestern Ontario N = 37 31 receivers and 6 nonreceivers of influenza vaccine Age >65, average age 82 years |
Fear of adverse reactions Perceptions of resilience to the vaccine-preventable disease |
Free access to influenza vaccinations in study location Vaccine uptake is greater in retirement homes Limited generalizability |
Boerner et al., 2013 11 | Vaccinating behaviours, the impact of public health messaging and the public’s attitudes toward H1N1 and the H1N1 vaccine | Fifteen focus group interviews | Ontario, Alberta and Manitoba N = 143 Equal size groups with ages: 18–34, 35–55 and 55+ years |
Access to vaccination | Recall bias Potential for statements to be influenced by focus group members and discussion |
Taddio et al., 2012 14 | Prevalence of needle fear in adults and children and the impact of needle fear on vaccine compliance | Cross-sectional survey | Ontario N = 2007; 883 parents & 1024 children Inclusion criteria: English speaking and experience with immunization |
Fear of needles | Reporting bias Study sample average education level higher than regional average Possible underreporting |
Roy et al., 2018 17 | Identify health and socio-demographic factors associated with nonvaccination | Canadian community health survey | Canada N = 108,700 divided into 3 groups: Adults aged 18 to 64 years with a chronic medical condition Adults aged ≥65 years Adults aged 18 to 64 years with no chronic medical condition |
Perceptions of resilience to the vaccine-preventable disease Antivaccine sentiments |
Recall bias Seniors in long-term care facilities and people living on Aboriginal reserves excluded Vaccination status based off 1 flu season |
Kiberd et al., 2010 22 | Explore attitudes and behaviours of Canadian adults regarding recommended vaccines | Web-based Canada-wide survey | Canada N = 4067 47.5% were 18–44, 35% 45–64 & 17.5% ≥65 years |
Access to vaccination Vaccine awareness Lack of vaccine information |
Limited to individuals with Internet access Recall bias |
Rousseau et al., 2007 24 | Explore the presence of barriers in relation to the organization of the health care system and to propose recommendations for increasing vaccine coverage | Telephone survey and small discussion groups | Quebec N = 996 Health care workers 22%, parents of children with chronic illness 11%, adults aged <60 with chronic disease 36%, people aged ≥60 31% |
Access to vaccination Lack of vaccine information |
Recall bias Selection bias |
Ozog et al., 2019 27 | Gauge public interest, HCP support, perceived barriers and perceived facilitators to influenza vaccine availability at ED | Short, anonymous, close-ended questionnaires over a 7-week period | Nova Scotia N = 230 150 adult clients who use the ED during the study period and 80 health care professionals currently working at the ED |
Access to vaccination | Study and results limited to ED setting |
Halperin et al., 2015 39 | Explore the knowledge, attitudes, beliefs and behaviours of the Canadian public regarding pertussis and pertussis vaccination | Web-based nationwide survey, a self-administered questionnaire format | Canada N = 4023 Subset of adults based on regional representation across the country, age, gender and urban and rural residence Participants were ≥18 years and had Internet access |
Vaccine awareness Lack of vaccine information |
Recall bias |
MacDougall et al., 2015 40 | Explore the knowledge, attitudes and behaviours of Canadian HCPs to identify barriers and facilitators to Tdap uptake | Survey, 8 focus groups and 4 interviews | Canada N = 1167 Family physicians 42.8%, internists 5.6%, pharmacists 34.3%, nurses 17.3% Focus groups N = 45 Family physicians 36%, pharmacists 27%, nurses 24%, general internists 4%, pediatricians 4% |
Antivaccine sentiment Access to vaccination Financial reasons Lack of vaccine information |
Potential for statements to be influenced by focus group members and discussion |
Prematunge et al., 2014 42 | Identify key motivators and barriers of HCWs to influenza vaccination in pandemic influenza and seasonal influenza settings | Survey packages | Ontario N = 3275 Nurses 35.2%, physicians 5.3%, allied HCWs 11.0%, administrative/clerical 22.0%, health care technicians 7.4%, research and laboratory 8.4%, facilities and logistics 6.6%, other nonclinical 4.1% |
Fear of adverse reaction Lack of vaccine information |
Sampling bias Overrepresentation of vaccinated HCWs Reported vaccination motivators and barriers may be somewhat subjective Lacks sensitivity to subtle barriers and motivators guiding HCW vaccination |
Zibrik et al., 2018 33 | Identify the impact of culturally relevant information and challenges with recommendations for effective public education and outreach programs | Pre- and postworkshop surveys and interviews | British Columbia N = 827 HBV education workshop participants (Chinese, Filipino, Korean and Punjabi immigrants) |
Access to vaccination Vaccine awareness Lack of vaccine information |
Limited generalizability |
Corace et al., 2013 12 | Identify the motivators and barriers to pH1N1 vaccine uptake among HCWs | Cross-sectional survey | Ontario N = 3275 Female 81%, white 89% |
Fear of adverse reaction Perceptions of resilience to the vaccine-preventable disease Effectiveness misconceptions Vaccine awareness |
Recall bias Limited generalizability Sampling bias |
Quach et al., 2013 10 | Strategies to achieve high immunization coverage in HCWs, barriers to uptake and perceptions of mandatory influenza immunization policies | Telephone interviews | Canada N = 44 23 influenza immunization program planners from 21 organizations |
Fear of adverse reactionEffectiveness misconceptions Negative personal experiences Antivaccine sentiments |
Themes explored were not preidentified and emerged during data analysis after interviews had been completed. Not all provinces and territories represented Limited generalizability |
Perez et al., 2013 13 | Examine knowledge, attitudes and beliefs about HPV and the HPV vaccine among a sample of Canadian males | Anonymous online questionnaire | Quebec N = 61 males with mean age of 20.7 years |
Vaccine awareness | Small sample size Limited generalizability |
Pullagura et al., 2020 15 | Understand community pharmacists’ attitudes towards and experiences with influenza VH and explore factors impacting their engagement with patients on the influenza vaccine | Semistructured interviews | Ontario N = 22 Most authorized to administer injections (n = 20, 90.9%) and practised for >20 years (n = 16, 72.7%) |
Antivaccine sentiment Access to vaccination |
Results reflect subjective experiences No formal assessment of interrater reliability Researcher bias Social desirability bias |
Piedimonte et al., 2018 16 | Determine the level of knowledge related to HPV and cervical cancer among university students and to subsequently develop a targeted education and vaccination campaign to increase uptake | Self-administered questionnaire | Quebec N = 56 Participants responded to a questionnaire; among these, 29 were vaccinated in a 2-day resident-run clinic |
Access to vaccination Financial reasons Perceptions of resilience to the vaccine-preventable disease |
Low participation and ability to provide continuous vaccination advertising |
Corace et al., 2011 18 | Examine the motivators and barriers influencing pH1N1 vaccination among HCWs to design and implement a more effective vaccine campaign that addresses these barriers | Mail-out survey | Ontario N = 3260 2848 who received the pH1N1 vaccine and 412 who refused |
Fear of adverse reaction Perceptions of resilience to the vaccine-preventable disease Effectiveness misconception Vaccine awareness |
Limited generalizability |
Giede et al., 2010 19 | Identify gaps in knowledge of the link between HPV infection, cervical dysplasia and cervical cancer among women attending the Student Health Services and to identify barriers to HPV vaccination among this cohort of women | 18-question survey | Saskatchewan N = 400 surveys distributed and 371 (91%) were returned |
Fear of adverse reaction Financial reasons Lack of vaccine information |
Limited generalizability |
Slaunwhite et al., 2009 20 | Increase awareness of the benefits associated with influenza vaccination | Sample t-test used to analyze difference between groups | Nova Scotia N = 23 |
Vaccine awareness | Limited generalizability |
Corace et al., 2011 23 | Design and implement more effective vaccine campaigns | Mail-out survey | Ontario N = 3260 2848 who received the pH1N1 vaccine and 412 who refused |
Fear of adverse reaction Perceptions of resilience to the vaccine-preventable disease Effectiveness misconception |
Limited generalizability |
Pielak et al., 2003 25 |
Compare students who were immunized or not immunized during the 1997 measles outbreak in British Columbia | Self-administered questionnaire | British Columbia N = 400 immunized and 400 nonimmunized university students |
Fear of adverse reaction Access to vaccination Financial reasons |
Attitudes and beliefs regarding measles may have differed before, during and after the measles outbreak. Variables comprising data collection instruments were not measured to provide proper resolution of dimensionality. |
Steben et al., 2019 26 | Identify HPV vaccination motivators and barriers among adults to lead to new approaches to improve HPV vaccination rates in nonpediatric populations | Online 16-item questionnaire | Canada N = 1252 802 HPV unvaccinated women and 250 vaccinated women aged 18 to 45 years, 200 men aged 18 to 26 years |
Fear of adverse reaction Antivaccine sentiment Financial reasons Lack of vaccine information |
Selection bias Unvaccinated women surveyed were on average older than the vaccinated women and responses may reflect age cohort trends and differential targeting of health information among groups |
Steben et al., 2019 28 | Explore knowledge, barriers and preventive practices regarding HPV vaccination | Survey using online panel | Canada N = 418 337 GPs, 81 OB/GYN |
Financial reasons | Response bias Survey administered before the release of July 2016 NACI guidelines with updated guidance on vaccine benefits |
Fernandes et al., 2018 29 | Determine the acceptability of catch-up HPV vaccination to undergraduate university women under the age of 25 by assessing their perceptions of HPV vaccination | Cross-sectional bilingual web-based survey | Ontario N = 401 female undergraduate students |
Fear of adverse reactionFinancial reasons Lack of vaccine information |
Response rate of survey was 17% Self-reported information with potential for recall and reporting errors |
McComb et al., 2018 30 | Explore reasons for lower uptake of HPV vaccine among new emigrants and refugees | Semistructured interviews | Saskatchewan N = 11 immigrant women, 18 to 26 years old |
Perceptions of resilience to the vaccine-preventable disease Lack of vaccine information |
Potential researcher bias Potential social desirability bias |
Mrklas et al., 2018 31 | Appraise the literature in Canadian and global Indigenous peoples, relating to documented barriers and supports to vaccination and interventions to increase acceptability/uptake or reduce hesitancy of vaccination | Systematic review of studies | Alberta Eligible studies include global Indigenous peoples and discuss barriers or supports and/or interventions to improve uptake or to reduce hesitancy for the HPV vaccine and/or other vaccines |
Financial reasons | |
Henderson et al., 2018 32 | Identify ways to increase HPV vaccination among people living in FN communities | Group dialogue | Alberta N = 24 community elders, parents, health directors and cancer survivors |
Negative personal experience Access to vaccination Potential sexual health promotion stigma |
Not a population-based cohort |
Tatar et al., 2017 35 | Evaluate the psychosocial correlates of HPV acceptability in college males, based on multiple stages of HPV decision-making | Online questionnaire | Quebec N = 428 College men aged 18 to 26 |
Vaccine awareness Lack of vaccine knowledge |
|
Scott and Batty, 2016 37 | Investigate factors related to HPV vaccine uptake in Canada and explore role of NPs in collaborating with public health agencies to expand knowledge and coverage of the HPV vaccine across Canada | Literature review | New Brunswick 4 electronic databases searched (PubMed, Google Scholar, Cumulative Index to Nursing and Allied Health Literature [CINAHL] and Medline) |
Antivaccine sentiment Lack of vaccine information |
|
Jones et al., 2016 38 | Identify socio-demographic and psychosocial predictors of HPV-related stigma and examine the relationship between HPV-related stigma in predicting HPV vaccine decision-making among college males | Self-reported survey | Canada N = 680 College males aged 18 to 26 |
Vaccine awareness Potential sexual health promotion stigma |
Study design does not allow the identification of causal relationships or the evaluation of changes over time Sampling methods used limit generalizability Study sample composed of younger college males compared to national average Many ethnic groups may be under-represented, including African Americans (5.3% in the current sample) |
MacDougall et al., 2015 41 | Assess the knowledge, attitudes, beliefs and behaviours of adults and health care providers related to 4 vaccine-preventable diseases and vaccines | Survey and focus groups | Canada N = 4023 general public’s survey N = 62 general public’s focus groups N = 1167 providers’ survey N = 45 providers’ focus groups |
Effectiveness misconceptions Access to vaccination Vaccine awareness |
Self-reporting of vaccine coverage status |
Pullagura et al., 2018 34 | Understand practising CP attitudes towards influenza VH, behaviour with those hesitant to receive the influenza vaccine and experiences with influenza VH at the community pharmacy | Telephone interviews | Ontario N = 22 CPs where 91% were certified to provide injections and 80% had >20 years of experience |
Access to vaccination | |
Steben et al., 2017 36 | A national survey of Canadians on HPV: comparing knowledge, barriers and preventive practices of physicians to those of consumers “To explore knowledge, barriers and preventive practices regarding HPV” |
Survey | Canada N = 418 physicians (n = 337 GPs and n = 81 OB/GYNs) N = 1139 women 18 to 45 years old (n = 337 vaccinated, n = 802 unvaccinated) N = 200 men between 18 and 26 years old |
Fear of adverse reaction Financial reasons Lack of vaccine knowledge |
|
Giede et al., 2010 21 | Identify knowledge gaps regarding the link between HPV infection, cervical dysplasia and cervical cancer, as well as barriers to HPV vaccination | 21-question survey | Saskatchewan N = 400 Survey response rate 91% (371 responses) |
Fear of adverse reaction Financial reasons Lack of vaccine information |
The participants were only from the University of Saskatchewan so the results cannot be generalized to the entire Canadian population. |
CP, community pharmacist; ED, emergency department; FN, First Nations; GP, general practitioner; HBV, hepatitis B virus; HCP, health care provider; HCW, health care worker; HPV, human papillomavirus; NACI, National Advisory Committee on Immunization; NP, nurse practitioner; OB/GYN, obstetrician/gynecologist; Tdap, tetanus, diphtheria and pertussis; VH, Vaccine hesitancy.
Of the 34 studies included in this review, 14 focused on barriers to human papillomavirus (HPV) vaccination and 12 on barriers to influenza vaccination. The remaining studies focused on multiple vaccines (4); tetanus, diphtheria and pertussis (Tdap) vaccine (2); hepatitis B vaccine (1) and measles vaccine (1).
The most frequently reported barriers were lack of vaccine information (41%), lack of access to vaccination (38%), fear of adverse reactions (38%), financial reasons (29%), lack of awareness of vaccine existence (29%), antivaccine sentiments (24%), the notion that older adults do not need vaccination (18%), misconceptions on vaccine effectiveness (12%), potential sexual health promotion stigma (6%) and fear of needles (3%).
Discussion
Current estimates are that up to 5% of the Canadian adult population has strong antivaccination views, while an additional 20% to 30% can be described as vaccine hesitant. 43 Vaccine hesitancy results in the refusal or delay in receiving vaccination. 4 Factors that contribute to vaccine hesitancy are a person’s lack of confidence or trust in the vaccine and/or health care provider; complacency, where the person does not see a need for the vaccine or does not see the value of the vaccine; fear of needles, blood or side effects from vaccines; and perceived inconvenient access to vaccines. 44 The greatest yield in improving vaccination rates is likely to come from supporting the significant number of vaccine-hesitant individuals in shifting their thinking to greater vaccine acceptance, rather than expending disproportionate effort on the relatively small number of people with strong antivaccination views. This review revealed that a lack of vaccine information, poor access to vaccination, fear of adverse reactions, financial barriers, poor awareness of vaccine existence and antivaccine sentiments as the most common reasons for vaccine hesitancy.
Strategies and interventions aimed to address the barriers and themes identified in this study have been well described by various groups in the past. As part of their COVID-19 Working Group, the Royal Society of Canada outlines the responsibility shared by health care providers to actively support vaccine acceptance in their communities. 45 As accessible and trusted health care providers, pharmacists are well positioned to address vaccine hesitancy by providing patient education based on the best available evidence and discussing risks and benefits associated with vaccination. 46 Pharmacist involvement through education, facilitation and administration of vaccines has been shown to increase patient uptake of vaccination. 47 Prioritizing these roles and implementing strategies targeting known barriers and determinants of vaccine hesitancy could help to improve vaccine acceptance (Box 1).
Box 1. Strategies to target known barriers and determinants of vaccine hesitancy.
• Prioritize role as vaccine educators and be prepared to provide information, correct misinformation and dispel myths.
○ Become familiar with the factors that contribute to vaccine hesitancy and how to best support patients depending on the specific concern or perceived barrier.
○ Ask open-ended questions and actively listen in order to identify specific patient concerns to ensure information is tailored appropriately.
○ Ensure you are current on latest vaccine information and be prepared to discuss benefits and risks of vaccines.
○ Present strong recommendations and share personal stories and experiences when able.
○ Have up-to-date and credible information readily available to provide patients.
• Be proactive in starting conversations about vaccines, making this a routine part of your practice.
○ Ask about vaccination status during all encounters and care activities and implement an immunization assessment to identify unmet needs.
○ Involve all pharmacy staff members in vaccine promotion by asking initial screening questions or identifying patients who have vaccine questions.
○ Adopt the mind-set that individuals are underimmunized unless you can confirm otherwise and hold the expectation that vaccination is the most probable outcome.
• Ensure vaccination services are convenient and easy to access.
○ Provide options for both prebooked appointments and walk-ins, or refer to a provider who can administer a vaccine in a timely manner.
○ Keep a small quantity of routinely requested vaccines on hand to provide vaccinations opportunistically.
○ Offer additional routine immunizations when providing annual influenza vaccines.
Lack of vaccine information
The most commonly cited barrier to vaccination in Canadian adults is lack of vaccine information. Participants were aware of the existence of a vaccine but had no further information on its efficacy and safety, where to receive it, the cost or if it was necessary at all. Canadians have unrestricted access to high-quality, evidence-based vaccine information written in patient-friendly language, available from organizations such as Immunize Canada and the Public Health Agency of Canada.48,49 Stakeholders should be focused on engaging Canadian adults in taking an interest in and seeking information about vaccines. Using a combination of interventions, such as face-to-face communication, health care provider training, community-based actions and mass media messages, appears to be much more effective than single-component interventions in raising awareness about vaccines. 50
Access to vaccination
Unlike structured childhood vaccination programs, administration of adult vaccines in Canada is less routine and highly dependent on the actions of primary health care providers. 51 An important barrier to vaccination is lack of access to vaccination (mentioned in 38% of studies). This barrier can be addressed by informing and referring people to health care professionals who have access to vaccines and are authorized to provide vaccination services. Most recommended vaccines are available at medical clinics, community pharmacies, community health centres, public health departments and travel clinics. Efforts are under way to evaluate an embedded community pharmacy-based approach aiming to improve vaccination rates in Canada utilizing pharmacist-delivered communicating and funding strategies. 52 According to 2018 Canadian survey data, more Canadian adults received their influenza vaccination at a pharmacy than any other location. 53 Recent reports highlight that pharmacists are well placed to improve access to vaccinations by using the annual influenza vaccination time to review and provide other adult immunizations as well. 54
Fear of adverse reactions
The second most common barrier identified was fear of adverse reactions. Despite overwhelming evidence supporting the safety of vaccines, lack of confidence in vaccine safety remains a major barrier to vaccination. Concerns range from fear of mild expected reactions such as injection site pain and redness to more serious but rare reactions such as anaphylaxis. Fears have been compounded by the spread of misinformation that vaccines can cause serious health problems such as developmental disorders or the very disease the vaccine is meant to protect against.
Seventy percent of Canadians use online resources for medical or health-related information. 55 Thus, educating patients and providing reliable sources of information may limit the need for Canadians to seek out information from unreliable Internet sources, which can be misleading or inaccurate. Health care provider transparency about potential adverse effects can build trust and has been shown to lower perceived risk. 56 Furthermore, it has been demonstrated that providing information about the adverse reaction reporting system may increase trust and vaccine acceptance among adults. 57
Some individuals believe that the risk of contracting a vaccine-preventable disease is lower than the risks of experiencing a severe adverse reaction from a vaccine. A randomized controlled trial showed that stories and images highlighting the beneficial impact of vaccination on such diseases improved attitudes towards vaccination, especially among vaccine-hesitant individuals. Although encouraging, evidence is needed to confirm the effectiveness of storytelling in changing people’s intentions to vaccinate. 58 According to a survey of primary care physicians in the United States, “the most common communication practices deemed very effective for convincing skeptical parents were personal statements by physicians about what they would do for their own children and about their personal experiences with vaccine safety among their patients.” 52 Similar strategies can help counter antivaccine sentiments, which was another prominent barrier in this review (24%). Additionally, health care providers should leverage their position as trusted vaccine resources for adults by discussing expected adverse reactions, explaining adverse reaction management and correcting misconceptions. Canadians identify health care providers (HCPs) as their most trusted source for vaccine information, and research has shown that HCP recommendations are one of the strongest predictors of vaccine acceptance.59,60
Financial barriers
Financial barriers are important concerns that affect immunization coverage in Canada. Vaccine recommendations in Canada are made by the National Advisory Committee on Immunization (NACI), while vaccine programs along with the decisions on vaccine coverage are implemented separately by each province or territory. 61 Most vaccines are provided free for Canadians, as these vaccines have proven to be cost-effective for the health care system. However, evaluation of the economic impact takes time and results in some new vaccines not being covered for all individuals. A practical cost consideration is lack of access to local clinics with open extended hours in a geographic area. As a result, patients have to plan ahead and consider taking time off work to follow the recommended vaccination schedule. 62 Most cost-associated barriers were in correlation with the HPV vaccination, as 1 dose of HPV costs about $185 and patients need 3 doses to gain immunity from 9 strains of HPV. 63 Influenza vaccination, when it is not publicly covered, costs about $25 to $30/dose. 64
Awareness of vaccine existence
A survey conducted by Halperin et al. 39 revealed that knowledge among adults about the Tdap vaccine was low, and only 36% of participants reported being aware that Tdap was recommended for all adults. Results of a cross-sectional study by Tatar et al. 35 showed a positive correlation between HPV vaccine acceptance and knowledge about HPV and having discussed the HPV vaccine with their health care provider. Events such as the National Immunization Awareness Week (NIAW) help highlight the importance of immunization and the impact of vaccines on preventing illness and death. Multiple organizations in Canada and around the world participate in this annual event to raise awareness about vaccines and improve vaccination rates. The Canadian government has committed millions of dollars to immunization initiatives for surveillance, education, outreach and guidance on the use of vaccines. 65 A study conducted by Shen and Dubey 6 suggests patients are not discussing vaccines early enough with their health care providers. When pharmacists discuss vaccination status and provide information to patients, vaccination rates improve. 66
Resilience of older adults
Immunosenescence, weakened immune function due to natural aging, results in increased susceptibility to infectious diseases, especially in those with underlying chronic illnesses. 67 As older adults are at higher risk of complications due to impaired immune function and comorbidities, it is essential to develop messaging and strategies to improve vaccine uptake in this population. 68 The misconception of natural immunity to the vaccine-preventable disease due to age can be addressed by health care professionals providing education on nonvaccination risks, as recommended by the Canadian Public Health Agency. 66
Limitations
This review had several limitations. As most of the included studies were related to influenza and HPV vaccines, which are inactivated, it is possible the barriers may differ if a live vaccine were evaluated, or for other types of vaccines. Furthermore, the barriers we found are a compilation of general public and health care professionals (who would presumably be better informed). When quantifying the barriers to vaccination, we reported crude rates of studies (rather than individuals) reporting the various barriers. Finally, this review does not include literature describing barriers to relatively newly developed vaccines, such as the COVID-19 vaccine.
Conclusion
Barriers to vaccination among Canadians and recent immigrants continue to challenge our health care system and contribute to vaccine hesitancy. Although decision-making regarding vaccination is complex and can be impacted by a number of factors, awareness of common barriers to vaccination has informed the development of strategies to improve vaccination uptake. Interventions to support vaccine-hesitant Canadians require effort and collaboration across all levels of our health care system. As trusted and accessible professionals, pharmacists are encouraged to incorporate vaccine assessments, preventive health and educational initiatives in their practice that may improve accessibility to vaccine services. ■
Supplemental Material
Supplemental material, sj-pdf-1-cph-10.1177_17151635221090212 for Barriers to adult vaccination in Canada: A qualitative systematic review by Doris Stratoberdha, Barbara Gobis, Adrian Ziemczonek, Jamie Yuen, Annita Giang and Peter J. Zed in Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
Footnotes
Author Contributions: DS was responsible for design and methodology, data collection and analysis. BG initiated the project and was responsible for design and methodology, data analysis. AZ wrote the manuscript and reviewed the final draft. JY and AG wrote the manuscript. PJZ supervised project and reviewed the final draft.
Declaration of Conflicts of Interest: The authors have no actual or potential conflicts of interest to declare.
Funding: This study was performed and the manuscript prepared without any financial support.
ORCID iDs: Barbara Gobis
https://orcid.org/0000-0003-0174-1137
Adrian Ziemczonek
https://orcid.org/0000-0002-3656-4954
Jamie Yuen
https://orcid.org/0000-0002-5020-4285
Peter J. Zed
https://orcid.org/0000-0002-8809-9206
Contributor Information
Doris Stratoberdha, Faculty of Pharmaceutical Sciences, the University of British Columbia, Vancouver, BC.
Barbara Gobis, Faculty of Pharmaceutical Sciences, the University of British Columbia, Vancouver, BC.
Adrian Ziemczonek, Faculty of Pharmaceutical Sciences, the University of British Columbia, Vancouver, BC.
Jamie Yuen, Faculty of Pharmaceutical Sciences, the University of British Columbia, Vancouver, BC.
Annita Giang, Faculty of Pharmaceutical Sciences, the University of British Columbia, Vancouver, BC.
Peter J. Zed, Faculty of Pharmaceutical Sciences and the Faculty of Medicine, the University of British Columbia, Vancouver, BC.
References
- 1. Greenwood B. The contribution of vaccination to global health: past, present and future. Phil Trans R Soc B 2014;369(1645):20130433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Government of Canada. Benefits of immunization: Canadian Immunization Guide. 2016. Available: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-1-key-immunization-information/page-3-benefits-immunization.html#p1c2a3 (accessed Jan. 14, 2021).
- 3. Dubé E, Gagnon D, Ouakki M, et al. Understanding vaccine hesitancy in Canada: results of a consultation study by the Canadian Immunization Research Network. PLoS One 2016;11(6):e0156118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Strategic Advisory Group of Experts on Immunization (SAGE). Report of the SAGE Working Group on Vaccine. Available: https://www.who.int/immunization/sage/meetings/2014/october/SAGE_working_group_revised_report_vaccine_hesitancy.pdf?ua = 1 (accessed Jan. 14, 2021). [Google Scholar]
- 5. Elflein J. Vaccinations in Canada—statistics & facts. Statista. Available: https://www.statista.com/topics/5216/vaccinations-in-canada/ (accessed Jan. 14, 2021). [Google Scholar]
- 6. Shen S, Dubey V. Addressing vaccine hesitancy: clinical guidance for primary care physicians working with parents. Can Fam Physician 2019;65(3):175-81. [PMC free article] [PubMed] [Google Scholar]
- 7. Government of Canada. Immunization of adults: Canadian Immunization Guide. 2015. Available: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-3-vaccination-specific-populations/page-2-immunization-of-adults.html (accessed Jan. 14, 2021).
- 8. Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med 2009;6(7):e1000097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. McIntyre A, Zecevic A, Diachun L. Influenza vaccinations: older adults’ decision-making process. Can J Aging 2014;33(1):92-8. [DOI] [PubMed] [Google Scholar]
- 10. Quach S, Pereira JA, Kwong JC, et al. Immunizing health care workers against influenza: a glimpse into the challenges with voluntary programs and considerations for mandatory policies. Am J Infect Control 2013;41(11):1017-23. [DOI] [PubMed] [Google Scholar]
- 11. Boerner F, Keelan J, Winton L, Jardine C, Driedger SM. Understanding the interplay of factors informing vaccination behavior in three Canadian provinces. Hum Vaccines Immunother 2013;9(7):1477-84. [DOI] [PubMed] [Google Scholar]
- 12. Corace K, Prematunge C, McCarthy A, et al. Predicting influenza vaccination uptake among health care workers: what are the key motivators? Am J Infect Control 2013;41(8):679-84. [DOI] [PubMed] [Google Scholar]
- 13. Perez S, King L, Jewish Z. College males HPV vaccine decision-making in the post-recommendation era. Psychooncology 2013;22(Suppl 3):357-8. [Google Scholar]
- 14. Taddio A, Ipp M, Thivakaran S, et al. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine 2012;30(32):4807-12. [DOI] [PubMed] [Google Scholar]
- 15. Pullagura GR, Violette R, Houle SKD, Waite NM. Shades of gray in vaccination decisions—understanding community pharmacists’ perspectives of, and experiences with, influenza vaccine hesitancy in Ontario, Canada. Vaccine 2020;38(11):2551-8. [DOI] [PubMed] [Google Scholar]
- 16. Piedimonte S, Leung A, Zakhari A, Giordano C, Tellier P-P, Lau S. Impact of an HPV education and vaccination campaign among Canadian university students. J Obstet Gynaecol Can 2018;40(4):440-6. [DOI] [PubMed] [Google Scholar]
- 17. Roy M, Sherrard L, Dube E, Gilbert NL. Determinants of non-vaccination against seasonal influenza. Health Rep 2018;29(10):12-22. [PubMed] [Google Scholar]
- 18. Corace K, Prematunga C, McCarthy A, et al. Why did health care workers refuse the pH1N1 vaccine during the pandemic? Can J Infect Dis Med Microbiol 2011;22(Suppl SA):13A. [Google Scholar]
- 19. Giede C, McFadden LL, Komonoski P, Agrawal A, Stauffer A, Pierson R. The acceptability of HPV vaccination among women attending the University of Saskatchewan Student Health Services. J Obstet Gynaecol Can. 2010;32(7):679-86. [DOI] [PubMed] [Google Scholar]
- 20. Slaunwhite JM, Smith SM, Fleming MT, Strang R, Lockhart C. Increasing vaccination rates among health care workers using unit “champions” as a motivator. Can J Infect Control. 2009;24(3):159-64. [PubMed] [Google Scholar]
- 21. Giede C, McFadden L, Komonoski P, Agrawal A, Stauffer A, Pierson R. Acceptability of HPV vaccination among women attending the University of Saskatchewan student health services. J Obstet Gynaecol Can 2010;116(3):598. [DOI] [PubMed] [Google Scholar]
- 22. Kiberd M, Slaunwhite J, Slayter K, et al. Changing low adult immunization rates in Canada: a public survey regarding facilitators and barriers to receipt of recommended vaccines among Canadian adults. A study from Can-AVERT (The Canadian Adult Vaccination Evaluation & Research Team). Can J Infect Dis Med Microbiol 2010;21(4):185-6. [Google Scholar]
- 23. Corace KM, Prematunga CB, McCarthy AE, et al. Motivators and barriers to pH1N1 vaccine uptake among healthcare workers. Am J Infect Control 2011;39(5):E75. [Google Scholar]
- 24. Rousseau L, Guay M, Archambault D, El m’ala Z, Abdelaziz N. Existe-t-il des barrieres organisationnelles a l’accessibilite a la vaccination contre l’influenza et le pneumocoque? [Do organizational barriers to pneumococcal and influenza vaccine access exist?]. Can J Public Health 2007;98(2):105-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Pielak KL, Hilton A. University students immunized and not immunized for measles: a comparison of beliefs, attitudes, and perceived barriers and benefits. Can J Public Health 2003;94(3):193-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Steben M, Durand N, Guichon JR, Greenwald ZR, McFaul S, Blake J. A national survey of Canadian adults on HPV: knowledge, attitudes, and barriers to the HPV vaccine. J Obstet Gynaecol Can 2019;41(8):1125-33.e6. [DOI] [PubMed] [Google Scholar]
- 27. Ozog N, Steenbeek A, Curran J, Kelly N. Staff and patient attitudes towards influenza vaccination availability during wait times at the Queen Elizabeth II Emergency Department, Halifax, Nova Scotia (in progress). Can J Emerg Med 2019;21(Suppl 1):S99. [Google Scholar]
- 28. Steben M, Durand N, Guichon JR, Greenwald ZR, McFaul S, Blake J. A national survey of Canadian physicians on HPV: knowledge, barriers, and preventive practices. J Obstet Gynaecol Can 2019;41(5):599-607.e3. [DOI] [PubMed] [Google Scholar]
- 29. Fernandes R, Potter BK, Little J. Attitudes of undergraduate university women towards HPV vaccination: a cross-sectional study in Ottawa, Canada. BMC Womens Health 2018;18(1):134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. McComb E, Ramsden V, Olatunbosun O, Williams-Roberts H. Knowledge, attitudes and barriers to human papillomavirus (HPV) vaccine uptake among an immigrant and refugee catch-up group in a western Canadian province.J Immigr Minor Health. 2018;20(6):1424-8. [DOI] [PubMed] [Google Scholar]
- 31. Mrklas KJ, MacDonald S, Shea-Budgell MA, et al. Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol. Syst Rev 2018;7(1):40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Henderson RI, Shea-Budgell M, Healy C, et al. First Nations people’s perspectives on barriers and supports for enhancing HPV vaccination: foundations for sustainable, community-driven strategies. Gynecol Oncol 2018;149(1):93-100. [DOI] [PubMed] [Google Scholar]
- 33. Zibrik L, Huang A, Wong V, et al. Let’s talk about B: barriers to hepatitis B screening and vaccination among Asian and South Asian immigrants in British Columbia. J Racial Ethn Health Disparities 2018;5(6):1337-45. [DOI] [PubMed] [Google Scholar]
- 34. Pullagura GR, Violette R, Houle S, Waite N. Shades of gray in vaccination decisions: understanding Ontario community pharmacists’ perspectives of and experiences with seasonal influenza vaccine hesitancy. Can Pharm J 2018;151(5):S29. [DOI] [PubMed] [Google Scholar]
- 35. Tatar O, Perez S, Naz A, Shapiro GK, Rosberger Z. Psychosocial correlates of HPV vaccine acceptability in college males: a cross-sectional exploratory study. Papillomavirus Res 2017;4:99-107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Steben M, Blake J, Durand N, Guichon J, McFaul S, Ogilvie G. A national survey of Canadians on HPV: comparing knowledge, barriers and preventive practices of physicians to those of consumers. Sex Transm Infect 2017;93(Suppl 2):A17-8. [Google Scholar]
- 37. Scott K, Batty ML. HPV vaccine uptake among Canadian youth and the role of the nurse practitioner. J Community Health 2016;41(1):197-205. [DOI] [PubMed] [Google Scholar]
- 38. Jones G, Perez S, Huta V, Rosberger Z, Lebel S. The role of human papillomavirus (HPV)-related stigma on HPV vaccine decision-making among college males. J Am Coll Health 2016;64(7):545-54. [DOI] [PubMed] [Google Scholar]
- 39. Halperin BA, MacDougall D, MacKinnon-Cameron D, et al. Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: what the Canadian public knows and wants to know. Vaccine 2015;33(48):6840-8. [DOI] [PubMed] [Google Scholar]
- 40. MacDougall D, Halperin BA, MacKinnon-Cameron D, et al. Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: what Canadian health care providers know and need to know. Hum Vaccines Immunother 2015;11(9):2167-79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. MacDougall D, Halperin BA, MacKinnon-Cameron D, et al. The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers. BMJ Open 2015;5(9):e009062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Prematunge C, Corace K, McCarthy A, et al. Qualitative motivators and barriers to pandemic vs. seasonal influenza vaccination among healthcare workers: a content analysis. Vaccine 2014;32(52):7128-34. [DOI] [PubMed] [Google Scholar]
- 43. Dawson T, Kirkey S. Who are the anti-vaxxers? Here’s what we know and how they got there in the first place. 2019. Available: https://nationalpost.com/news/canada/who-are-the-anti-vaxxers (accessed Jan. 14, 2021).
- 44. Kumar D, Chandra R, Mathur M, Samdariya S, Kapoor N. Vaccine hesitancy: understanding better to address better. Isr J Health Policy Res. 2016;5:2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. MacDonald NE, Comeau J, Dubé E, et al. Royal Society of Canada COVID-19 report: enhancing COVID-19 vaccine acceptance in Canada. FACETS 2021;6:1184-246. [Google Scholar]
- 46. Lisenby KM, Patel KN, Uichanco MT. The role of pharmacists in addressing vaccine hesitancy and the measles outbreak. J Pharm Pract. 2021;34(1):127-32. [DOI] [PubMed] [Google Scholar]
- 47. Isenor JE, Bowles SK. Evidence for pharmacist vaccination. Can Pharm J (Ott) 2018;151(5):301-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Immunize Canada. Available: https://immunize.ca (accessed Jan. 14, 2021).
- 49. Health Canada, Public Health Agency of Canada. Vaccines and immunization. 2021. Available: https://www.canada.ca/en/public-health/services/immunization-vaccines.html (accessed Jan. 14, 2021).
- 50. Dubé E, Gagnon D, MacDonald N; SAGE Working Group on Vaccine Hesitancy. Strategies intended to address vaccine hesitancy: review of published reviews. Vaccine 2015;33(34):4191-203. [DOI] [PubMed] [Google Scholar]
- 51. Busby C. Not just for kids: how to improve adult vaccination uptake in Canada. 2018. Available: https://www.cdhowe.org/sites/default/files/attachments/research_papers/mixed/Commentary_509.pdf (accessed Jan. 14, 2021).
- 52. Isenor JE, Kervin MS, Halperin DM, et al. Pharmacists as immunizers to improve coverage and provider/recipient satisfaction: a prospective, controlled community embedded study with vaccines with low coverage rates (the improved ACCESS study): study summary and anticipated significance. Can Pharm J (Ott) 2020;153(2):88-94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Government of Canada. Vaccine uptake in Canadian adults 2019. Available: https://www.canada.ca/en/public-health/services/publications/healthy-living/2018-2019-influenza-flu-vaccine-coverage-survey-results.html (accessed Jan. 14, 2021).
- 54. Kempe A, Daley M, McCauley M, Babbel C, Seewald L, Dickinson L. Prevalence of parental concerns about childhood vaccines: the experience of primary care physicians. Am J Prev Med 2011;40(5):548-55. [DOI] [PubMed] [Google Scholar]
- 55. Statistics Canada. Canadian Internet Use Survey. 2011. Available: https://www150.statcan.gc.ca/n1/daily-quotidien/100510/dq100510a-eng.htm (accessed Jan. 14, 2021).
- 56. Betsch C, Sachse K. Debunking vaccination myths: strong risk negations can increase perceived vaccination risks. J Health Psychol 2013;32(2): 146-55. [DOI] [PubMed] [Google Scholar]
- 57. Scherer LD, Shaffer VA, Patel N, Zikmund-Fisher BJ. Can the vaccine adverse event reporting system be used to increase vaccine acceptance and trust? Vaccine 2016;34(21):2424-9. [DOI] [PubMed] [Google Scholar]
- 58. Horne Z, Powell D, Hummel J, Holyoak K. Countering antivaccination attitudes. Proc Natl Acad Sci U S A 2015;112(33):10321-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Dubé E, Gagnon D, Zhou Z, Deceuninck G. Parental vaccine hesitancy in Quebec (Canada). PLoS Curr 2016;8:ecurrents.outbreaks.9e239605f4d320c6ad27ce2aea5aaad2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Violette R, Pullagura GR. Vaccine hesitancy: moving practice beyond binary vaccination outcomes in community pharmacy. Can Pharm J (Ott) 2019;152(6):391-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Public Health Agency of Canada. Provincial and territorial routine vaccination programs for healthy, previously immunized adults. 2020. Available: https://www.canada.ca/en/public-health/services/provincial-territorial-immunization-information/routine-vaccination-healthy-previously-immunized-adult.html (accessed Jan. 16, 2021).
- 62. Ernst K, Jacobs E. Implications of philosophical and personal belief exemptions on re-emergence of vaccine-preventable disease: the role of spatial clustering in undervaccination. Hum Vaccin Immunother 2012;8(6):838-41. [DOI] [PubMed] [Google Scholar]
- 63. Vancouver Coastal Health. HPV 9 vaccine provides wider protection. Available: http://travelclinic.vch.ca/handouts/hpv/ (accessed Jan. 18, 2021).
- 64. Ozog N. Attitudes towards influenza vaccination during “wait times” in the emergency department. 2019. Available: https://dalspace.library.dal.ca/bitstream/handle/10222/75443/Ozog-Noelle-MSc-Nurs-Mar-2019.pdf?sequence = 3 (accessed Jan. 18, 2021).
- 65. Health Canada and the Public Health Agency of Canada. Office of Audit and Evaluation. Evaluation of immunization and respiratory infectious disease activities at the public health agency of Canada 2011-2012 to 2015-2016. 2016. Available: https://www.canada.ca/en/public-health/corporate/mandate/about-agency/office-evaluation/evaluation-reports/evaluation-immunization-respiratory-infectious-disease-activities-2011-2012-2015-2016.html (accessed Jan. 16, 2021).
- 66. Isenor JE, Killen JL, Billard BA, et al. Impact of pharmacists as immunizers on influenza vaccination coverage in the community-setting in Nova Scotia, Canada: 2013-2015. J Pharm Policy Pract 2016;19(9):32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Dorrington MG, Bowdish DME. Immunosenescence and novel vaccination strategies for the elderly. Front Immunol 2018;4:171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Demicheli V, Jefferson T, Ferroni E, Rivetti A, Pietrantonj C. Vaccine for preventing influenza in healthy adults. Cochrane Database Syst Rev 2018;2(2):CD001269. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental material, sj-pdf-1-cph-10.1177_17151635221090212 for Barriers to adult vaccination in Canada: A qualitative systematic review by Doris Stratoberdha, Barbara Gobis, Adrian Ziemczonek, Jamie Yuen, Annita Giang and Peter J. Zed in Canadian Pharmacists Journal / Revue des Pharmaciens du Canada